<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK368474" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK368474/" /><meta name="ncbi_pagename" content="FOXP2-Related Speech and Language Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FOXP2-Related Speech and Language Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FOXP2-Related Speech and Language Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/02/02" /><meta name="citation_author" content="Angela Morgan" /><meta name="citation_author" content="Simon E Fisher" /><meta name="citation_author" content="Ingrid Scheffer" /><meta name="citation_author" content="Michael Hildebrand" /><meta name="citation_pmid" content="27336128" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK368474/" /><meta name="citation_keywords" content="FOXP2-Only-Related Disorders" /><meta name="citation_keywords" content="FOXP2-Plus-Related Disorders" /><meta name="citation_keywords" content="Forkhead box protein P2" /><meta name="citation_keywords" content="FOXP2" /><meta name="citation_keywords" content="FOXP2-Related Speech and Language Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FOXP2-Related Speech and Language Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Angela Morgan" /><meta name="DC.Contributor" content="Simon E Fisher" /><meta name="DC.Contributor" content="Ingrid Scheffer" /><meta name="DC.Contributor" content="Michael Hildebrand" /><meta name="DC.Date" content="2017/02/02" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK368474/" /><meta name="description" content="All FOXP2-related speech and language disorders, regardless of the underlying genetic alteration, have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS – whether caused by an alteration of FOXP2 or of an unknown cause – have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in FOXP2-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments." /><meta name="og:title" content="FOXP2-Related Speech and Language Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="All FOXP2-related speech and language disorders, regardless of the underlying genetic alteration, have a core phenotype: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS – whether caused by an alteration of FOXP2 or of an unknown cause – have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in FOXP2-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK368474/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/foxp2-sl-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK368474/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B96F7E04026F100000000068A0249.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK368474_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK368474_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fragilex/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mota/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK368474_"><span class="title" itemprop="name"><i>FOXP2-</i>Related Speech and Language Disorders</span></h1><p class="contrib-group"><span itemprop="author">Angela Morgan</span>, BSpPath (Aud Hons), PhD, <span itemprop="author">Simon E Fisher</span>, DPhil, <span itemprop="author">Ingrid Scheffer</span>, MBBS, PhD, FRACP, FAA, and <span itemprop="author">Michael Hildebrand</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK368474_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK368474_ai__"><div class="contrib half_rhythm"><span itemprop="author">Angela Morgan</span>, BSpPath (Aud Hons), PhD<div class="affiliation small">Director of Research and Teaching, Department of Audiology and Speech Pathology<br />University of Melbourne<br />Director, Neuroscience of Speech<br />Murdoch Children's Research Institute<br />Victoria, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.bleminu@roma" class="oemail">ua.ude.bleminu@roma</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Simon E Fisher</span>, DPhil<div class="affiliation small">Max Planck Institute for Psycholinguistics<br />Donders Institute for Brain, Cognition and Behavior<br />Radboud University<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.ipm@rehsif.nomis" class="oemail">ln.ipm@rehsif.nomis</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ingrid Scheffer</span>, MBBS, PhD, FRACP, FAA<div class="affiliation small">Epilepsy Research Centre<br />Department of Medicine and Paediatrics<br />University of Melbourne<br />Austin Health<br />Victoria, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.bleminu@reffehcs.i" class="oemail">ua.ude.bleminu@reffehcs.i</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michael Hildebrand</span>, PhD<div class="affiliation small">Epilepsy Research Centre<br />Melbourne Brain Centre<br />Department of Medicine<br />University of Melbourne<br />Austin Health<br />Victoria, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.bleminu@dnarbedlih.leahcim" class="oemail">ua.ude.bleminu@dnarbedlih.leahcim</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 23, 2016</span>; Last Revision: <span itemprop="dateModified">February 2, 2017</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="foxp2-sl-dis.Summary" itemprop="description"><h2 id="_foxp2-sl-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>All <i>FOXP2-</i>related speech and language disorders, regardless of the underlying genetic alteration, have a core <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. All individuals with CAS &#x02013; whether caused by an alteration of <i>FOXP2</i> or of an unknown cause &#x02013; have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in <i>FOXP2</i>-related speech and language disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; and reading and spelling impairments.</p><p>The underlying genetic cause of <i>FOXP2-</i>related speech and language disorders is either disruption of <i>FOXP2</i> only (referred to in this <i>GeneReview</i> as <i>FOXP2</i>-only-related speech and language disorder) or large copy number variants (i.e., contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions), structural variants (i.e., <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or inversion), or maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of chromosome 7 (UPD7) involving <i>FOXP2</i> (here referred to as <i>FOXP2</i>-plus speech and language disorders). The genetic alteration determines if only speech and language problems are present (<i>FOXP2</i>-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (<i>FOXP2</i>-plus speech and language disorder). In <i>FOXP2-</i>only<i>-</i>related disorders, nonverbal (performance) IQ is typically more preserved compared to verbal IQ. Fine motor skills may be impaired (e.g., buttoning clothes, tying shoelaces), yet gross motor skills are normal. Autistic features and <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> findings have been reported in a few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. In <i>FOXP2-</i>plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorder are common.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a <i>FOXP2-</i>related speech and language disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of one of the following:</p><ul><li class="half_rhythm"><div>A large non-recurrent <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that includes <i>FOXP2</i> (52% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>A sequence variant within <i>FOXP2</i> (~29%)</div></li><li class="half_rhythm"><div>Maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7 (UPD7) that reduces <i>FOXP2</i> expression (~11%)</div></li><li class="half_rhythm"><div>A structural variant (e.g., <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, inversion) that disrupts <i>FOXP2</i> (~8%)</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Optimally management of the speech and/or language disorder is determined by a speech pathologist based on the individual's findings (typically: presence and severity of CAS, dysarthria, language deficits, and literacy impairments). A clinical psychologist or neuropsychologist may provide strategies to help manage deficits in specific cognitive domains and an occupational therapist and physiotherapist can provide strategies to help with fine and gross motor deficits, respectively.</p><p><i>Surveillance:</i> Follow-up evaluations with standardized tests by a speech and language pathologist.</p><p><i>Evaluation of relatives at risk:</i> Clarification of the genetic status of pre-symptomatic relatives at risk identifies as early as possible those who would benefit from prompt evaluation for speech and language disorders and initiation of treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Recurrence risk for sibs of <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>FOXP2-</i>related speech and language disorder depends on the genetic alteration:</p><p>Non-recurrent contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions (80% are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and the remainder are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner)</p><p><i>FOXP2</i> sequence variants (~70% are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and the remainder are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner)</p><p>Maternal UPD7 (no increased risk to sibs)</p><p>A structural variant (e.g., <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, inversion. If one parent has a structural variant, the risk to sibs is increased and depends on the specific structural variant.)</p><p>Prenatal testing and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the causative genetic alteration has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="foxp2-sl-dis.GeneReview_Scope"><h2 id="_foxp2-sl-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="foxp2-sl-dis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_foxp2-sl-dis.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXP2-</i>Related Speech and Language Disorders: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_foxp2-sl-dis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>FOXP2</i>-only-related disorders</div></li><li class="half_rhythm"><div><i>FOXP2</i>-plus-related disorders</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#foxp2-sl-dis.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="foxp2-sl-dis.Diagnosis"><h2 id="_foxp2-sl-dis_Diagnosis_">Diagnosis</h2><div id="foxp2-sl-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A <i>FOXP2-</i>related speech and language disorder <b>should be suspected</b> in a child with <b>childhood apraxia of speech (CAS)</b> [<a class="bk_pop" href="#foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</a>] (also known as developmental verbal dyspraxia, verbal dyspraxia, or speech dyspraxia) and <b>additional clinical findings</b>.</p><p><b>CAS</b></p><ul><li class="half_rhythm"><div>Children with CAS have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences.</div></li><li class="half_rhythm"><div>The diagnosis of CAS is made by assessment by a speech-language pathologist (also known as a speech and language therapist in the UK). CAS is challenging to diagnose in a child younger than age three years: speech development is delayed in these children, and thus key manifestations are typically not seen or able to be elicited until the child has acquired sufficient speech to complete the verbal assessment tasks.</div></li></ul><p><b>Additional clinical findings</b></p><ul><li class="half_rhythm"><div>Delayed speech development</div></li><li class="half_rhythm"><div>Poor oral motor function (e.g., excessive drooling, early feeding difficulties)</div></li><li class="half_rhythm"><div>Oral motor difficulties and/or oral motor dyspraxia</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Receptive and expressive language impairment</div></li><li class="half_rhythm"><div>Low average IQ, typically with poorer verbal IQ compared to nonverbal IQ (and average nonverbal IQ reported in some)</div></li><li class="half_rhythm"><div>Mild dysmorphology may rarely be present</div></li><li class="half_rhythm"><div>Autistic features may rarely be present</div></li><li class="half_rhythm"><div>Reading and spelling impairment</div></li><li class="half_rhythm"><div>Fine and gross motor impairment</div></li></ul></div><div id="foxp2-sl-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a <i>FOXP2-</i>related speech and language disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by detection of ONE of the following (see <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTmoleculargenetictesting" rid-ob="figobfoxp2sldisTmoleculargenetictesting">Table 1</a>):</p><ul><li class="half_rhythm"><div>A large non-recurrent <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that includes <i>FOXP2</i> (52% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>A sequence variant within <i>FOXP2</i> (~29%)</div></li><li class="half_rhythm"><div>Maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7 (UPD7) that reduces <i>FOXP2</i> expression (~11%)</div></li><li class="half_rhythm"><div>A structural variant (e.g., <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, inversion) that disrupts <i>FOXP2</i> (~8%).</div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> [CMA] and comprehensive genomic sequencing) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>FOXP2-</i>related speech and language disorders is broad, children with the distinctive findings described in <a href="#foxp2-sl-dis.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <b>Option 1</b>), whereas a more severe phenotype that includes developmental delay (DD)/intellectual disability (ID) may be indistinguishable from many other inherited disorders with DD/ID and is more likely to be diagnosed using genomic testing (see <b>Option 2</b>).</p><p><b>Option 1. Gene-targeted testing.</b> When the clinical findings suggest the diagnosis of a <i>FOXP2-</i>related speech and language disorder, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FOXP2</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FOXP2</i> and other genes of interest (see <a href="#foxp2-sl-dis.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. ((2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p><b>Methylation testing</b> for maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> (UPD) of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7 should be considered in individuals with verbal dyspraxia and features suggestive of <a href="/books/n/gene/rss/">Silver-Russell syndrome</a>, since UPD accounted for about 12% of cases in one study [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>].</p><p>Note: <i>FOXP2</i> has not been demonstrated to be an <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Although <i>FOXP2</i> is located on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7, the mechanistic relationship between UPD7 and <i>FOXP2</i> function has not been established.</p><p><b>Option 2. Genomic testing.</b> When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders with language delay and developmental delay/intellectual disability, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (CMA, comprehensive genomic sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>CMA</b> should be the first genetic test as about 52% of <i>FOXP2</i>-related speech and language disorders are caused by large non-recurrent deletions that encompass <i>FOXP2</i> and flanking DNA.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Further testing</b> to consider:</div><ul><li class="half_rhythm"><div><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequencing</b> (when clinically available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div><b>Karyotype.</b> An apparently balanced <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or pericentromeric inversion involving <a href="/projects/mapview/maps.cgi?taxid=9606&#x00026;chr=7&#x00026;query=FOXP2&#x00026;qstr=FOXP2&#x00026;maps=snp,genes-r,pheno&#x00026;zoom=2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q31.1</a>, the <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a><i>,</i> has been observed in about 8% of <i>FOXP2-</i>plus-related disorders and <i>FOXP2-</i>only-related disorders.</div></li></ul><div class="half_rhythm">Note: A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> for inherited disorders of speech delay and developmental delay/intellectual disability may be considered.</div></li></ul><div id="foxp2-sl-dis.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FOXP2-</i>Related Speech and Language Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr><tr><th headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FOXP2</i>-plus</th><th headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3" id="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXP2-</i>only</th></tr></thead><tbody><tr><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXP2</i></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">34/65 (52%)&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/65 (29%)&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Methylation testing (to detect UPD)</td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/65 (~11%)&#x000a0;<sup>9</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype (to detect structural variants)</td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/65 (~8%)&#x000a0;<sup>10</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>11</sup></td><td headers="hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_1_3 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_1 hd_h_foxp2-sl-dis.T.molecular_genetic_testing_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="foxp2-sl-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK368474/#foxp2-sl-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="foxp2-sl-dis.TF.1.2"><p class="no_margin">See <a href="#foxp2-sl-dis.Molecular_Genetics">Molecular Genetics</a> and <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTfoxp2pathogenicvariants" rid-ob="figobfoxp2sldisTfoxp2pathogenicvariants">Table 3</a> for information on reported genetic alterations and phenotypes.</p></div></dd><dt>3. </dt><dd><div id="foxp2-sl-dis.TF.1.3"><p class="no_margin">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis (<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> approach) detects <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>FOXP2</i> and other contiguous genes using a <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that specifically includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>4. </dt><dd><div id="foxp2-sl-dis.TF.1.4"><p class="no_margin"><a href="/projects/dbvar/clingen/clingen_gene.cgi?sym=foxp2&#x00026;subject=" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinGen-19248</a>. Standardized clinical annotation and interpretation for <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants from the <a href="http://www.clinicalgenome.org/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clinical Genome Resource (ClinGen) project</a> (formerly the International Standards for Cytogenomic Arrays [ISCA] Consortium).</p></div></dd><dt>5. </dt><dd><div id="foxp2-sl-dis.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al [2006]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al [2007]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.palka.2012.e183">Palka et al [2012]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al [2012]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al [2012]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.adegbola.2015.6848">Adegbola et al [2015]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</a></p></div></dd><dt>6. </dt><dd><div id="foxp2-sl-dis.TF.1.6"><p class="no_margin">One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#foxp2-sl-dis.REF.palka.2012.e183">Palka et al 2012</a>].</p></div></dd><dt>7. </dt><dd><div id="foxp2-sl-dis.TF.1.7"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and splice-site variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>8. </dt><dd><div id="foxp2-sl-dis.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al [2005]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.roll.2010.4848">Roll et al [2010]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al [2012]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al [2013]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="foxp2-sl-dis.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</a></p></div></dd><dt>10. </dt><dd><div id="foxp2-sl-dis.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2000.357">Lai et al [2000]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al [2006]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al [2009]</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.moralli.2015.36">Moralli et al [2015]</a></p></div></dd><dt>11. </dt><dd><div id="foxp2-sl-dis.TF.1.11"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="foxp2-sl-dis.Clinical_Characteristics"><h2 id="_foxp2-sl-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="foxp2-sl-dis.Clinical_Description"><h3>Clinical Description</h3><p><i>FOXP2-</i>related speech and language disorders &#x02013; regardless of the underlying genetic alteration &#x02013; have a core <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>: childhood apraxia of speech (CAS), a disorder of speech motor programming or planning that affects the production, sequencing, timing, and stress of sounds, syllables, and words. Individuals with CAS (whether caused by an alteration of <i>FOXP2</i> or of an unknown cause) have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with the correct prosody. Additional findings in <i>FOXP2</i>-related speech disorders can include oral motor dyspraxia (difficulty planning or programming oral movements on command); dysarthria (a neuromuscular-based speech disorder that may affect nasal resonance, voice quality, prosody, and breath support for speech); moderate to severe receptive and expressive language disorder; reading and spelling impairments; more preserved non-verbal IQ compared to verbal IQ; and fine motor difficulties. "Autistic features" or a diagnosis of autism spectrum disorder (ASD) has been reported in some, but not all cases. Similarly typically mild dysmorphology has been reported in a few cases only.</p><p>The underlying genetic alteration of <i>FOXP2-</i>related speech and language disorders is one of the following:</p><ul><li class="half_rhythm"><div>Disruption of <i>FOXP2</i> only &#x02013; here referred to as <i>FOXP2</i>-only-related speech and language disorders</div></li><li class="half_rhythm"><div>Large copy number variants (i.e., contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions) or structural variants (i.e., <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or inversion) involving <i>FOXP2</i> &#x02013; here referred to as <b><i>FOXP2</i>-plus speech and language disorders</b></div></li></ul><p>The genetic alteration determines if only speech and language problems are present (<i>FOXP2</i>-only-related speech and language disorder) or if more global developmental and behavioral issues are likely to be present as well (<i>FOXP2</i>-plus speech and language disorder).</p><p>In <i>FOXP2-</i>only<i>-</i>related disorders nonverbal (performance) IQ is typically relatively preserved compared to verbal IQ and gross motor skills are normal. In <i>FOXP2-</i>plus-related disorders oral motor deficits, global developmental delay, and autism spectrum disorders are commonly seen.</p><p>To date, available evidence suggests that <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>FOXP2</i> (including whole- or partial-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions) cause the motor speech disorder known as childhood apraxia of speech (CAS) which interferes non-selectively with multiple aspects of language, including phonology, grammar, and literacy. The interactions between these communication disorder subtypes are not well understood. Language and literacy difficulties may be influenced by or even result from CAS, or these phenotypes may actually be features of the same broad communication disorder.</p><p><b>Childhood apraxia of speech</b> (CAS), a disorder of speech motor planning/programming, is the core <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>FOXP2-</i>related speech and language disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>].</p><p>CAS affects the production, sequencing, timing, and stress of sounds, syllables, and words [<a class="bk_pop" href="#foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</a>]; thus, children with CAS have difficulties in automatically and accurately sequencing speech sounds into syllables, syllables into words, and words into sentences with appropriate prosody.</p><p>First words are reported to appear between ages 18 months and seven years in children with <i>FOXP2-</i>only-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>] and <i>FOXP2-</i>plus-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</a>]. <i>FOXP2-</i>related speech and language disorders are typically diagnosed around age three to four years, but may be considered earlier when the family history is positive.</p><p>In the first decade of life, speech is highly unintelligible, even to close friends and family. Although speech development and intelligibility improve over time, speech never develops to the same level as age-matched peers; intelligibility may remain reduced even in the third and fourth decades of life [<a class="bk_pop" href="#foxp2-sl-dis.REF.fee.1995.189">Fee 1995</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al 2006</a>]. Note: The <a class="bk_pop" href="#foxp2-sl-dis.REF.fee.1995.189">Fee [1995]</a> study of members of the KE family was conducted prior to the identification of a causative <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members by <a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</a>.</p><p>In contrast, for typically developing children, speech sound acquisition is mastered by around age eight years [<a class="bk_pop" href="#foxp2-sl-dis.REF.dodd.2003.617">Dodd et al 2003</a>] with intelligibility as high as 97% as early as age three years [<a class="bk_pop" href="#foxp2-sl-dis.REF.flipsen.2006.303">Flipsen 2006</a>].</p><p>Although CAS comprises certain core features, it is important to note that the severity and features of CAS change across the life span [<a class="bk_pop" href="#foxp2-sl-dis.REF33">Royal College of Speech and Language Therapists 2011</a>] and while referred to as "core" features, they are not necessarily present in all individuals with CAS [<a class="bk_pop" href="#foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</a>]. Core features, agreed upon by a consensus panel, include the following:</p><ul><li class="half_rhythm"><div>Inconsistent speech errors (e.g., producing the same syllable or word differently across repetitions of the same word such as "ubella," "umbrella," "umbarella" for umbrella)</div></li><li class="half_rhythm"><div>Lengthened and disrupted co-articulatory transitions (e.g., oral groping behaviors during speech; difficulty sequencing phonemes and syllables; difficulty maintaining syllable integrity; hypernasality [thought to be due to incoordination of velum for denoting oral/nasal contrasts]; slowed and disrupted diadochokinetic sequences [e.g., when asked to repeat "pa-ta-ka"])</div></li><li class="half_rhythm"><div>Inappropriate prosody (e.g., lexical stress errors, equal stress across words giving a robotic-sounding presentation)</div></li></ul><p>In addition, children with CAS tend to lag behind their peers in acquiring the sounds of their language system; hence, their phonetic inventory may be reduced for the child's age. Children with CAS may use a more restricted range of consonants and vowels than age-matched peers. For example, they will simplify syllable shapes, reducing a consonant-consonant-vowel shape (CCV) (e.g., "sta") or a CCCV shape ("stra") to a consonant-vowel (CV) shape ("sa").</p><p>Although CAS is distinct from other speech disorders (e.g., stuttering, phonologic disorder) and language disorders (e.g., specific language impairment), these additional diagnoses can technically co-occur with CAS.</p><p><b>Additional common speech- and language-related comorbidities</b> in <i>FOXP2-</i>related speech and language disorders can include the following &#x02013; irrespective of underlying genetic alteration:</p><ul><li class="half_rhythm"><div>Oral motor dyspraxia, an inability or difficulty in planning or programming of oral movements on command, including single movements in isolation (e.g., commands such as "blow"; "bite"; "stick out your tongue") or sequences of oral movements (e.g., commands such as "bite and blow"; "touch your bottom lip with your tongue and then your top lip"). Oral dyspraxia has been more commonly reported than oral motor deficits per se in <i>FOXP2-</i>only-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.1998.12695">Vargha-Khadem et al 1998</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.alcock.2000.17">Alcock et al 2000</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2000.357">Lai et al 2000</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>], in contrast to <i>FOXP2</i>-plus-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>].</div></li><li class="half_rhythm"><div>Dysarthria, which is typically classified as spastic [<a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.morgan.2010">Morgan et al 2010</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>]. Typical dysarthric features include hypernasality, impaired laryngeal quality, and difficulties modulating pitch and loudness.</div></li><li class="half_rhythm"><div>Moderate to severe receptive and expressive language disorder [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al 2009</a>]. Expressive language is usually poorer than receptive language, with expressive language likely confounded by the presence of CAS. Impaired performance across both semantic and syntactic language domains has been reported in <i>FOXP2</i>-related speech and language disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>]. Affected  semantic domains include naming accuracy and lexical decision making; affected  syntactic domains include past tense production for regular and irregular verbs.</div></li><li class="half_rhythm"><div>Reading and spelling impairments, which are evident once literacy develops [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</a>]. Difficulties with real word and non-word reading, spelling, and phonologic awareness skills have been noted in some individuals with <i>FOXP2</i>-related speech and language disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>]. Of note, the literacy skills of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have rarely been discussed in case reports and &#x02013; given the link between speech and literacy disorders &#x02013; deficits are likely to be underrecognized.</div></li></ul><p><b>Other features of <i>FOXP2-</i>only<i>-</i>related disorders</b></p><ul><li class="half_rhythm"><div>Generally stronger nonverbal (performance) IQ compared to verbal IQ [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem et al 1995</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>] and compared to children with <i>FOXP2</i>-plus-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al 2009</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</a>]. Based on data from the largest family reported to date (which also has the most comprehensive IQ phenotyping available), it appears that in addition to lower verbal IQ (presumably <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by CAS and comorbid expressive language deficits), nonverbal (performance) IQ may also be lower than average in some areas (e.g., coding subtest; see <a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al [2002)</a>. Further, relative strengths in nonverbal IQ have been previously reported in block design and object assembly subtests of IQ measures [<a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>], notably tasks relying on visual processing.</div></li><li class="half_rhythm"><div>Normal fine and gross motor skills are seen in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2001.519">Lai et al 2001</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.watkins.2002.452">Watkins et al 2002</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</a>] but others with FOXP2-only disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>], or <i>FOXP2</i>-plus-related disorders [<a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</a>] have fine motor deficits. Fine or gross motor impairments are reported as relatively mild compared to the marked speech production deficits [<a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2000.357">Lai et al 2000</a>]. Overall however, relatively little attention has been given in the literature to the possible presence of general motor deficits.</div></li><li class="half_rhythm"><div>Some features of ASD have been observed and formal diagnoses of ASD have been made in a small number of recently reported individuals; however, the data suggest that these behavioral issues are not a core feature [<a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>].</div></li><li class="half_rhythm"><div>Mild dysmorphology reported in a small number of individuals, included high arch palate, horizontal eyebrows, simply folded ears [<a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>] submucous cleft palate was reported in one individual [<a class="bk_pop" href="#foxp2-sl-dis.REF.li_geois.2016.35192">Li&#x000e9;geois et al 2016</a>]</div></li></ul><p><b>Other features of <i>FOXP2</i>-plus-related disorders</b></p><ul><li class="half_rhythm"><div>Oral motor deficits commonly reported [<a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</a>]</div></li><li class="half_rhythm"><div>"Global" developmental delay (presumably involving speech, cognitive, gross, and fine motor abilities) [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>]</div></li><li class="half_rhythm"><div>Autism spectrum disorder (ASD) [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</a>] or presence of features of ASD such as repetitive behaviors and unusual interests [<a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</a>]. Of note, many individuals with <i>FOXP2-</i>only-related disorders are explicitly stated not to meet diagnostic criteria for ASD [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al 2012</a>], suggesting that these features may relate to disruption of neighboring genes on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7.</div></li><li class="half_rhythm"><div>Facial dysmorphology [<a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al 2006</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al 2007</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al 2012</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al 2017</a>]. Oral structures are typically intact in the absence of a cleft lip or palate, but a high arched palate has been reported in one individual [<a class="bk_pop" href="#foxp2-sl-dis.REF.palka.2012.e183">Palka et al 2012</a>].</div></li></ul><p><b>Neuroimaging</b></p><p>Clinical brain MRIs of individuals with a <i>FOXP2</i>-related speech and language disorder reportedly appear normal on visual inspection [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.1998.12695">Vargha-Khadem et al 1998</a>].</p><p>In contrast, sophisticated quantitative MRI data acquisition and analysis techniques suggest that bilateral subcortical volume reductions are strong markers of <i>FOXP2</i> disruption in childhood based on findings in (1) members of the KE family with the <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Arg553His compared to unaffected family members [<a class="bk_pop" href="#foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem et al 2005</a>] and (2) one individual with the <i>FOXP2</i> pathogenic variant Gln415ValfsTer5 [<a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al 2013</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.li_geois.2016.35192">Li&#x000e9;geois et al 2016</a>]. Because data are limited further studies are required to understand the generalizability of this finding.</p><p>Click <a href="/books/NBK368474/bin/foxp2-sl-dis-neuroimaging.pdf">here</a> (pdf) for detailed information on neuroimaging findings in the KE family, the first (and largest) family for which published imaging data are reported.</p></div><div id="foxp2-sl-dis.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>The specific genetic alteration responsible for a <i>FOXP2</i>-related speech and language disorder does not predict clinical severity. However, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>FOXP2-</i>plus-related disorders tends to be more severe overall (given the increased risk for the additional clinical features of global developmental delay and a formal diagnosis of autism spectrum disorder) compared to the phenotype of <i>FOXP2-</i>only<i>-</i>related disorders. See <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTfoxp2pathogenicvariants" rid-ob="figobfoxp2sldisTfoxp2pathogenicvariants">Table 3</a> for reported genetic alterations and phenotypes.</p></div><div id="foxp2-sl-dis.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> for this severe speech and language disorder is high, close to 100% based on reported cases.</p></div><div id="foxp2-sl-dis.Nomenclature"><h3>Nomenclature</h3><p>Prior to the discovery of <i>FOXP2,</i> the <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> "speech language disorder-1 (SPCH1)" was assigned to the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region linked to the CAS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#foxp2-sl-dis.REF.fisher.1998.168">Fisher et al 1998</a>]<i>.</i></p></div><div id="foxp2-sl-dis.Prevalence"><h3>Prevalence</h3><p>The population prevalence of childhood apraxia of speech (CAS) has not been determined by any epidemiologic study. The most commonly referenced estimate of prevalence is 1-2:1000 population [<a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.1997.273">Shriberg et al 1997</a>]. Of note, no data are available to determine what proportion of CAS is caused by disruption of <i>FOXP2</i> only or large copy number variants or structural variants involving <i>FOXP2.</i></p><p>In a cohort with a severe speech disorder, one of 49 individuals had a confirmed <i>FOXP2</i>-related speech and language disorder, whereas a previously unreported <i>FOXP2</i> variant of uncertain clinical significance was detected in two additional unrelated individuals [<a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al 2005</a>].</p><p>In an independent cohort with a CAS diagnosis, a previously unreported <i>FOXP2</i> variant of uncertain clinical significance was detected in one of 24 individuals [<a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al 2012</a>].</p><p>Of note, beyond these studies of CAS, other studies of cohorts with different disorders of speech and language development have not reported individuals with pathogenic <i>FOXP2</i> coding variants (e.g., see <a class="bk_pop" href="#foxp2-sl-dis.REF.han.2014.23">Han et al [2014]</a> for a study of developmental stuttering, <a class="bk_pop" href="#foxp2-sl-dis.REF.gauthier.2003.172">Gauthier et al [2003]</a> for a study of autistic disorder, and <a class="bk_pop" href="#foxp2-sl-dis.REF.newbury.2002.1318">Newbury et al [2002]</a> for a study of autism and specific language impairment).</p></div></div><div id="foxp2-sl-dis.Genetically_Related_Allelic"><h2 id="_foxp2-sl-dis_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>FOXP2</i>.</p></div><div id="foxp2-sl-dis.Differential_Diagnosis"><h2 id="_foxp2-sl-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>The prelinguistic developmental history of children with childhood apraxia of speech (CAS) (e.g., restricted babbling or feeding difficulties) is very similar to that seen in other neurodevelopmental speech or language conditions (e.g., specific language impairment, phonologic disorder) or even other neurodevelopmental disorders in which language impairment may occur such as autism spectrum disorders (ASDs). Hence, early signs are not usually sufficiently discriminating to enable a differential diagnosis prior to a child gaining some speech production abilities.</p><p>The primary feature of the <i>FOXP2</i>-related speech and language disorders is CAS, a rare diagnosis. Other developmental speech and language disorders, such as stuttering and phonologic production disorder, are distinguishable on a speech and language assessment.</p><p>While CAS is rare, it may also be observed in a range of other conditions. The following may be considered in the differential diagnosis.</p><p><b>Unknown cause of CAS.</b> Although the clinical manifestations and developmental history of children with CAS of unknown cause is almost indistinguishable from that of children with <i>FOXP2</i>-related CAS, speech prognosis appears poorer for individuals with <i>FOXP2</i>-related CAS. No studies have systematically compared the two populations.</p><p><b>Known causes of CAS.</b> Disorders to consider in the differential diagnosis of <i>FOXP2</i>-related speech and language disorders are listed in <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.disorders_to_consider_in/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTdisorderstoconsiderin" rid-ob="figobfoxp2sldisTdisorderstoconsiderin">Table 2</a><b>.</b> The clinical features of these disorders vary; most can be diagnosed by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA).</p><div id="foxp2-sl-dis.T.disorders_to_consider_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>FOXP2</i>-Related Speech and Language Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.T.disorders_to_consider_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.T.disorders_to_consider_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" style="text-align:left;vertical-align:middle;"><i>Gene</i> or Critical Region</th><th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" style="text-align:left;vertical-align:middle;">CAS</th><th id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping (in addition to CAS)</th><th headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5" id="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing</th></tr></thead><tbody><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/del16p11_2/">16p11.2 microdeletion</a></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AUTS14</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ID, ASD, DD</div></li><li class="half_rhythm"><div>Expressive language skills more severely impaired than receptive language</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Epilepsy or recurrent seizures</div></li><li class="half_rhythm"><div>Dysmorphic features (e.g., low-set ears, partial syndactyly)</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dup7q11_23/">7q11.23 duplication syndrome</a></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">WBSCR</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+&#x000a0;<sup>3</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Appropriate nonverbal pragmatic abilities in socially comfortable situations</div></li><li class="half_rhythm"><div>Oral apraxia</div></li><li class="half_rhythm"><div>Phonologic disorder</div></li><li class="half_rhythm"><div>Expressive language disorder</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Dysmorphic features (brachycephaly, broad forehead, straight eyebrows, broad nasal tip, low insertion of the columella, short philtrum, thin upper lip, minor ear anomalies, facial asymmetry)</div></li><li class="half_rhythm"><div>Social anxiety</div></li><li class="half_rhythm"><div>Developmental coordination disorder</div></li></ul>
In some:
<ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Visually detectable MRI abnormalities (e.g., vermis hypoplastic, ventriculomegaly, vermis hypoplasia)</div></li><li class="half_rhythm"><div>Signs of cerebellar dysfunction</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mdel17q21_31/"><i>KANSL1</i>-related intellectual disability syndrome</a></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KANSL1</i></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early oral motor &#x00026; feeding difficulties</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Oral dyspraxia</div></li><li class="half_rhythm"><div>Expressive language abilities better than receptive language</div></li><li class="half_rhythm"><div>Literacy problems</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Dysmorphic features (elongated face, bulbous nasal tip)</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Visual &#x00026;/or hearing deficits</div></li><li class="half_rhythm"><div>Heart problems</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRIN2A</i>-related disorders&#x000a0;<sup>4</sup><br /><a href="http://omim.org/entry/245570" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GRIN2A</i></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1;</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Oral dyspraxia</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Aphasia</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Epilepsy</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Worster-Drought syndrome&#x000a0;<sup>5</sup><br /><a href="http://omim.org/entry/185480" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebral palsy&#x000a0;<sup>6</sup></div></li><li class="half_rhythm"><div>Oral dyspraxia</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Mild fine &#x00026; gross movement difficulties</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Moderate learning difficulties</div></li><li class="half_rhythm"><div>Club feet</div></li><li class="half_rhythm"><div>Restricted joint movement</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fhs/">Floating-Harbor syndrome</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SRCAP</i></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+&#x000a0;<sup>7</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Hypernasality</div></li><li class="half_rhythm"><div>Severe expressive &#x00026; receptive language &#x00026; literacy impairment</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Delayed bone age</div></li><li class="half_rhythm"><div>Characteristic facies</div></li><li class="half_rhythm"><div>Aggression in childhood</div></li></ul>
</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/galactosemia/">Galactosemia</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALT</i></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+&#x000a0;<sup>9</sup></td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Expressive/receptive language impairment</div></li><li class="half_rhythm"><div>Typical or borderline-low IQ to more severe IQ depending on type of galactosemia&#x000a0;<sup>10</sup></div></li><li class="half_rhythm"><div>Dysarthria</div></li></ul>
</td><td headers="hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_1_5 hd_h_foxp2-sl-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Movement coordination disorder, primarily affecting balance &#x00026; manual dexterity</div></li><li class="half_rhythm"><div>Voice dysfunction</div></li><li class="half_rhythm"><div>Liver function issues</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; ASD = autism spectrum disorder; CAS = childhood apraxia of speech; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="foxp2-sl-dis.TF.2.1"><p class="no_margin">Most pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div></dd><dt>2. </dt><dd><div id="foxp2-sl-dis.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.fedorenko.2016.310">Fedorenko et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="foxp2-sl-dis.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.velleman.2011.108">Velleman &#x00026; Mervis [2011]</a></p></div></dd><dt>4. </dt><dd><div id="foxp2-sl-dis.TF.2.4"><p class="no_margin">Landau Kleffner syndrome and epilepsy-aphasia syndromes</p></div></dd><dt>5. </dt><dd><div id="foxp2-sl-dis.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.clark.2000.2160">Clark et al [2000]</a></p></div></dd><dt>6. </dt><dd><div id="foxp2-sl-dis.TF.2.6"><p class="no_margin">Cerebral palsy may be associated with brain damage or malformation such as bilateral perisylvian polymicrogyria (excessive and small gyri).</p></div></dd><dt>7. </dt><dd><div id="foxp2-sl-dis.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.white.2010.821">White et al [2010]</a></p></div></dd><dt>8. </dt><dd><div id="foxp2-sl-dis.TF.2.8"><p class="no_margin">The prevalence of motor speech disorder in this group is high; in one study ~25% of children had CAS [<a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.2011.487">Shriberg et al 2011</a>].</p></div></dd><dt>9. </dt><dd><div id="foxp2-sl-dis.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.potter.2013.31">Potter et al [2013]</a></p></div></dd><dt>10. </dt><dd><div id="foxp2-sl-dis.TF.2.10"><p class="no_margin">Individuals with the Gln188Arg/Gln188Arg <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> may be at increased risk for cognitive and language impairments.</p></div></dd></dl></div></div></div></div><div id="foxp2-sl-dis.Management"><h2 id="_foxp2-sl-dis_Management_">Management</h2><div id="foxp2-sl-dis.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and management needs for an individual with a <i>FOXP2-</i>related speech and language disorder, the following evaluations conducted by a trained and specialized speech-language pathologist are recommended:</p><ul><li class="half_rhythm"><div>Detailed developmental history including early oral motor and feeding abilities, speech sound development, motor milestones, and cognitive development</div></li><li class="half_rhythm"><div>Family history of speech disorder</div></li><li class="half_rhythm"><div>Oral-facial structural examination to determine if any structural abnormalities are present</div></li><li class="half_rhythm"><div>Assessment of oral motor function including:</div><ul><li class="half_rhythm"><div>Examination of cranial nerve function for evidence of asymmetry, reduced or increased tone, and/or poor coordination of neuromuscular movements</div></li><li class="half_rhythm"><div>Examination for evidence of oral motor dyspraxia (e.g., can the patient perform oral movements on command in isolation [e.g., "bite" or "blow"] or in sequence [e.g., "kiss and blow"; "kiss, blow, and bite"])</div></li></ul></li><li class="half_rhythm"><div>Speech sound assessment including a test of single words, sounds in isolation, and connected speech to determine the child's phonetic inventory (i.e., has the child acquired age-appropriate speech sounds) and to determine if the child has articulation errors, phonologic errors, apraxic errors, dysarthric errors, or a combination of these errors. The presence of resonance or nasality deficits signals the need to consider whether such structurally based velopharyngeal port incompetence is present by referral to an ear, nose, and throat specialist and possibly videopalatography.</div></li><li class="half_rhythm"><div>Language assessment to determine the presence of receptive and/or expressive language impairments across the domains of semantics, syntax, and morphology</div></li><li class="half_rhythm"><div>Literacy assessment or pre-literacy (phonologic awareness) for evidence of reading and spelling difficulties</div></li><li class="half_rhythm"><div>Social skills assessment for the presence of autistic features</div></li></ul><p>Additional evaluations:</p><ul><li class="half_rhythm"><div>Referral to a neuropsychologist or clinical psychologist to determine the extent of any coexisting cognitive and learning impairments and to examine for the presence of behaviors associated with autism spectrum disorder</div></li><li class="half_rhythm"><div>Referral to a physiotherapist if gross motor movement difficulties are reported and an occupational therapist if fine motor movement difficulties are observed</div></li><li class="half_rhythm"><div>Consideration of MRI to evaluate for the presence of a neurologic lesion if indicated</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="foxp2-sl-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Speech and language deficits</b>. A speech pathologist will utilize treatments targeted to the specific findings in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual; hence, the importance of a thorough initial assessment to establish the extent of disease and management needs for an individual. No single recommended treatment exists.</p><p>The optimal approach should be determined based on the individual's findings regarding:</p><ul><li class="half_rhythm"><div>CAS [<a class="bk_pop" href="#foxp2-sl-dis.REF3">American Speech-Language-Hearing Association 2007</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.morgan.2008.cd006278">Morgan &#x00026; Vogel 2008</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF33">Royal College of Speech and Language Therapists 2011</a>];</div></li><li class="half_rhythm"><div>Dysarthria [<a class="bk_pop" href="#foxp2-sl-dis.REF.pennington.2009.cd006937">Pennington et al 2009</a>];</div></li><li class="half_rhythm"><div>Language deficits [<a class="bk_pop" href="#foxp2-sl-dis.REF.law.2003.cd004110">Law et al 2003</a>];</div></li><li class="half_rhythm"><div>Literacy impairments [<a class="bk_pop" href="#foxp2-sl-dis.REF.snowling.2012.27">Snowling &#x00026; Hulme 2012</a>].</div></li></ul><p><b>Cognitive deficits</b>. A clinical psychologist or neuropsychologist may provide strategies to help manage deficits in specific cognitive or social skill domains.</p><p><b>Fine and gross motor deficits.</b> An occupational therapist and physiotherapist can provide strategies to help with these issues.</p></div><div id="foxp2-sl-dis.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Routine care by a general pediatrician</div></li><li class="half_rhythm"><div>Follow-up evaluations with standardized tests by a speech and language pathologist</div></li></ul></div><div id="foxp2-sl-dis.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the <i>FOXP2</i> genetic alteration in the family to identify as early as possible those who would benefit from prompt evaluation and initiation of treatment.</p><p>See <a href="#foxp2-sl-dis.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="foxp2-sl-dis.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>A number of therapies for childhood apraxia of speech (CAS) are under investigation [<a class="bk_pop" href="#foxp2-sl-dis.REF.morgan.2008.cd006278">Morgan &#x00026; Vogel 2008</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.murray.2014.486">Murray et al 2014</a>, <a class="bk_pop" href="#foxp2-sl-dis.REF.murray.2015">Murray et al 2015</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="foxp2-sl-dis.Genetic_Counseling"><h2 id="_foxp2-sl-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="foxp2-sl-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Genetic counseling for a <i>FOXP2-</i>related speech and language disorders depends on the causative genetic alteration:</p><ul><li class="half_rhythm"><div>Large non-recurrent <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> that includes <i>FOXP2</i>; 80% are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and the remainder are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner (see <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTfoxp2pathogenicvariants" rid-ob="figobfoxp2sldisTfoxp2pathogenicvariants">Table 3</a>).</div></li><li class="half_rhythm"><div>Sequence variant within <i>FOXP2</i>; ~70% are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and the remainder are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</div></li><li class="half_rhythm"><div>Maternal <a class="def" href="/books/n/gene/glossary/def-item/uniparental-disomy/">uniparental disomy</a> of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 7 (UPD7); <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> is not increased over that of the general population.</div></li><li class="half_rhythm"><div>Structural variant (e.g., <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>, inversion) that disrupts <i>FOXP2</i>; <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> depends on the specific structural variant.</div></li></ul></div><div id="foxp2-sl-dis.Risk_to_Family_Members__Lar"><h3>Risk to Family Members &#x02013; Large Non-Recurrent Contiguous Gene Deletion including <i>FOXP2</i></h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> are generally unaffected.</div></li><li class="half_rhythm"><div>The majority of deletions are <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> [<a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al 2006</a>].</div></li><li class="half_rhythm"><div>Evaluation of the parents by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing that will detect the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not identified in one of the parents, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If one of the parents has the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to each sib of inheriting the deletion is 50%; however, it is not possible to reliably predict clinical severity in sibs who inherit the deletion.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> have a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>; however, it is not possible to reliably predict clinical severity in offspring who inherit the deletion.</p></div><div id="foxp2-sl-dis.Risk_to_Family_Members__Seq"><h3>Risk to Family Members &#x02013; Sequence Variant within <i>FOXP2</i></h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>30% of individuals with a sequence variant within <i>FOXP2</i> have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent<i>.</i></div></li><li class="half_rhythm"><div>70% of individuals with a <i>FOXP2</i> sequence variant have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to determine if the variant was inherited or is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband.</div></li><li class="half_rhythm"><div>If the <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FOXP2</i> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents:</div><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>If the <i>FOXP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> have a 50% chance of inheriting the <i>FOXP2</i> sequence variant.</p></div><div id="foxp2-sl-dis.Risk_to_Family_Members__Str"><h3>Risk to Family Members &#x02013; Structural Variant</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Evaluation of the parents by karyotyping that will detect the structural variant present in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended.</div></li><li class="half_rhythm"><div>The proportion of parents carrying a structural variant is not known.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>If one of the parents has the structural variant identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to sibs is increased and depends on the specific structural variant.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Risk to offspring depends on the specific structural variant.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>FOXP2</i> genetic alteration, his or her family members may be at risk.</p></div><div id="foxp2-sl-dis.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#foxp2-sl-dis.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations when a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents an apparently <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case.</b> When neither parent of a proband with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder has the genetic alteration identified in the proband, the genetic alteration is likely <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk of having a child with a <i>FOXP2</i>-related speech and language disorder.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="foxp2-sl-dis.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the genetic alteration causative of a <i>FOXP2-</i>related speech and language disorder has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD) are possible.</p><p>Note: While prenatal testing and PGD can be used to detect a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> genetic alteration associated with a <i>FOXP2</i>-plus-related disorder or a <i>FOXP2</i>-only-related disorder, severity of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> cannot be predicted on the basis of test results.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="foxp2-sl-dis.Resources"><h2 id="_foxp2-sl-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Apraxia Kids</b></div><div>1501 Reedsdale Street </div><div>Suite 202</div><div>Pittsburgh PA 15233</div><div><b>Phone:</b> 412-785-7072</div><div><a href="https://www.apraxia-kids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apraxia-kids.org</a></div></li><li class="half_rhythm"><div><b>Childhood Apraxia of Speech Association of North America (CASANA)</b></div><div><a href="http://www.apraxia-kids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apraxia-kids.org</a></div></li><li class="half_rhythm"><div><b>Childhood Apraxia of Speech Support Australia</b></div><div>Australia</div><div><a href="http://www.casaustralia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.casaustralia.org</a></div></li><li class="half_rhythm"><div><b>Dyspraxia Foundation</b></div><div>United Kingdom</div><div><b>Phone:</b> 01462 455 016</div><div><b>Fax:</b> 01462 455 052</div><div><b>Email:</b> dyspraxia@dyspraxiafoundation.org.uk</div><div><a href="https://www.dyspraxiafoundation.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dyspraxiafoundation.org.uk</a></div></li></ul></div><div id="foxp2-sl-dis.Molecular_Genetics"><h2 id="_foxp2-sl-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="foxp2-sl-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FOXP2-Related Speech and Language Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/93986" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FOXP2</i></a></td><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=93986" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15409" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Forkhead box protein P2</a></td><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FOXP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP2 database</a></td><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FOXP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP2</a></td><td headers="hd_b_foxp2-sl-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FOXP2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FOXP2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="foxp2-sl-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="foxp2-sl-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FOXP2-Related Speech and Language Disorders (<a href="/omim/602081,605317" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602081" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602081</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPEECH-LANGUAGE DISORDER 1; SPCH1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605317" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605317</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FORKHEAD BOX P2; FOXP2</td></tr></tbody></table></div></div><p><b>Gene structure.</b> Of the 18 <i>FOXP2</i> transcripts reported on <a href="http://www.ensembl.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ensembl</a>, 13 are protein coding. The canonic transcript according to Ensembl (CCDS43635; <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_148898</a>; <a href="https://www.ncbi.nlm.nih.gov/protein/NP_683696" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_683696</a>) is 6443 base pairs long, encodes 740 amino acids, and consists of 18 exons, 17 of which contain coding sequence.</p><p>The most commonly referenced isoform in the literature (CCDS5760; <a href="/nuccore/NM_014491" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014491</a>; <a href="/nuccore/NP_055306" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055306</a>) is 2638 base pairs long, encodes 715 amino acids, and consists of 17 exons, 16 of which contain coding sequence. Given its high expression in human tissues, this isoform is most frequently used for variant nomenclature.</p><p><b>Pathogenic variants.</b> Pathogenic variants associated with <i>FOXP2-</i>related disorders and the reported phenotypes are summarized in <a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTfoxp2pathogenicvariants" rid-ob="figobfoxp2sldisTfoxp2pathogenicvariants">Table 3</a>.</p><div id="foxp2-sl-dis.T.foxp2_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>FOXP2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__foxp2-sl-dis.T.foxp2_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br /><a href="/nuccore/NM_014491" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014491</a><br />(<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_148898</a>)</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein Change<br /><a href="/nuccore/NP_055306" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055306</a><br />(<a href="https://www.ncbi.nlm.nih.gov/protein/NP_683696" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_683696</a>)</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># Cases</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sex</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ethnicity</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language &#x00026; Literacy</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognition</th><th id="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" colspan="11" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Intragenic <i>FOXP2</i> variants&#x000a0;<sup>1</sup></b></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.50A&#x0003e;T<br />(50A&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln17Leu&#x000a0;<sup>2</sup><br />(Gln17Leu)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Northern European</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.562_573ins12<br />(637_648ins12)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln188_Gln191dup&#x000a0;<sup>2</sup><br />(Gln213_Gln216dup)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Northern European</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.982C&#x0003e;T<br />(1057C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg328Ter&#x000a0;<sup>2</sup><br />(Arg353Ter)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2y-4y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M<br />2F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Northern European</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS, nonverbal, poor clarity</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oropharyngeal dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive, simple grammar</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comprehension difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Motor dyspraxia</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.982C&#x0003e;T<br />(1057C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg328Ter<br />(Arg353Ter&#x000a0;<sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: 14y; 2: 35y (Mo)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M, F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: CAS, "slurred articulation"<br />2: History of stuttering, CAS, &#x00026; learning difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Severe receptive &#x00026; expressive language deficit; spoke in simple sentences<br />2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: NVIQ low normal range at 8y; FSIQ borderline at 14y3m<br />2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Friendly disposition; school for special needs; normal EEG; Morphology: high nasal root; pointed nasal tip, prominent incisors, an overbite, tapering fingers &#x00026; broad feet<br />2: NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1168_1169delCA<br />(1243_1244delCA)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln390Valfs<br />(Gln415Valfs&#x000a0;<sup>4</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Australian</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral-motor apraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Borderline IQ</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1432C&#x0003e;T<br />(1507C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg478Ter<br />(Arg503Ter&#x000a0;<sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: 4.5y; 2: 6.5y; 3: 36y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F, 2M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Philippines</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: NR<br />2: NR<br />3: Slurred articulation</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: "Mild delay," 3-word sentences at 4.5 y<br />2: "Severe delay," 5 words at 6.5 y<br />3: Limited development beyond 1st words at 7 y; speaks simple sentences; can "read &#x00026; write well"</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Delayed motor development: mildly backwards, rotated, relatively large ears w/uplifted earlobes &#x00026; horizontal eyebrows;<br />2: Abnormal hair whorls, backwards rotated relatively large ears w/uplifted earlobes, horizontal eyebrows, wide intermammillary distance &#x00026; fetal pads (fingers &#x00026; toes);<br />3: Horizontal eyebrows &#x00026; mildly uplifted earlobes; disability pension, lives w/parents.</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1432C&#x0003e;T<br />(1507C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg478Ter<br />(Arg503Ter <sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Persistent speech impairment 6y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Good grades in German language class &#x00026; written tests</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limited auditory memory capacity; good at maths; ongoing speech &#x00026; occupational therapies; narrow palpebral fissures, high arched palate, mild finger pads, EEG normal, audiometry normal; strabismus, hyperopia, astigmatism</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1514C&#x0003e;T<br />(1589C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro505Leu<br />(Pro530Leu <sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: 6.5y; 2: 40y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: German-Thai;<br />2: German</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Mostly unintelligible<br />2: "Articulation disorder"; speech therapy ongoing</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Impaired expressive &#x00026; receptive<br />2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Borderline IQ<br />2: Average IQ at age 29y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: NR<br />2: Working as industrial mechanic.</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1217T&#x0003e;C<br />(1292T&#x0003e;C)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met406Thr&#x000a0;<sup>5</sup><br />(Met431Thr)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2F<br />2M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Turkish</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Polymicrogyria</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1658G&#x0003e;A<br />(1733G&#x0003e;A)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg553His&#x000a0;<sup>6</sup><br />(Arg578His)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 gen</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">English</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orofacial dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Borderline IQ</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1607G&#x0003e;C<br />(1682G&#x0003e;C)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg536Pro<br />(Arg561Pro&#x000a0;<sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: 10y10m;2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1F<br />1M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Impaired expressive &#x00026; receptive<br />2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Borderline IQ<br />2: NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1: Friendly, some autisitic features (no formal diagnosis), mildly hypotonic.<br />2: NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1614delT<br />(1689delT)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe538Leufs<br />(Phe563Leufs&#x000a0;<sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Poor pronunciation, no fluent speech at 15y; stilted intonation, stuttering and reluctance to speak at 19y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Poor expressive language at 15y<br />Better receptive language w/appropriate responses to questions at 15y<br />Able to read at write</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ASD diagnosis at 15y; mainstream school w/support; good at math &#x00026; computers; morphology: small simply folded ears, prominent nose &#x00026; chin w/large protruding tongue, myopia</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1690C&#x0003e;T<br />(1765C&#x0003e;T)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg564Ter<br />(Arg589Ter&#x000a0;<sup>3</sup>)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9y11m</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ASD diagnosis at 9y11m, mainstream school w/learning support; fine motor deficits; unusual coughing sounds like choking as young child; normal hearing, left exotropia.</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1789A&#x0003e;C<br />(1864A&#x0003e;C)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn597His&#x000a0;<sup>7</sup><br />(Asn622His)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7-9y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NAD</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion exons 12-17&#x000a0;<sup>3</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 (monozygotic twins)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">"Slurred articulation"</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speak in short sentences; reading &#x00026; writing impaired</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FSIQ 1: 78; 2: 79<br />Verbal comp: 77; 67<br />Perceptual reasoning: 86; 88<br />Working memory: 82; 88<br />Processing speed: 88; 103</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Friendly &#x00026; shy; normal EEG, morphology: epicanthic folds, mildly upslanting palpebral fissures, prominent incisors, sandal gaps.</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" colspan="11" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b><i>FOXP2</i> disruption by <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a></b></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">t(3;7)(q23;q31.2)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Translocation&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">t(5;7)(q22;q31.2)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Translocation&#x000a0;<sup>6,</sup>&#x000a0;<sup>9</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Verbal dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe orofacial dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal nonverbal skills</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">t(7;13)(q31.1;q13.2)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Translocation&#x000a0;<sup>10,</sup>&#x000a0;<sup>11</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18-52y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">American</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS; spastic dysarthria</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No orofacial apraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low average</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" colspan="11" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b><i>FOXP2</i> and additional <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</b></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31<br />(2 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Upstream <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>12</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Verbal dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NAD</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dyslexia</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.31<br />(8.3 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>13</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-28y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Estonian</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Poor vocabulary</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate developmental delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autistic features, eye disorder</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.2<br />(6.5 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>13</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6y/NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Estonian</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NAD</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Poor vocabulary</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate ID</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aggressive</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.3<br />(14.8 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>14</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Italian</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Borderline IQ</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fine praxis &#x00026; balance problems</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.2<br />(1.57 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>15</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4-24y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M/F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">American</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS, dysarthria</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gagging &#x00026; drooling</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely impaired</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low average / borderline IQ</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fine &#x00026; gross motor planning difficulty, PDD-NOS</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.2<br />(9.1 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>16</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">M</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Drooling, low oral motor tone</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate ID</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.3<br />(16 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>17</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5y</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Italian</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Verbal dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severely impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Below average</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.3<br />(11 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ASD</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q31.3<br />(15 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q33<br />(30 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.1-q33<br />(30 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.2-q32<br />(13 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.2-q32<br />(14 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.2-q32<br />(15 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31.2-q32<br />(26 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ASD</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q22-q31.3<br />(15 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor difficulties</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cognitive impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q22-q31.33<br />(22 Mb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Language delay</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10 hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" colspan="11" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other / Complex variants</b></td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7q31<br />(28 kb)</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pericentromeric inversion&#x000a0;<sup>18,</sup>&#x000a0;<sup>19</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">F</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Substitution, omission, mistiming of single articulations in a sequence</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Specific language impairment</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal-low range</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impulsive behavior, sleep disturbance, obsessive compulsive symptoms, auditory hallucinations (all ceased following medication)</td></tr><tr><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">UPD7</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Uniparental disomy&#x000a0;<sup>8</sup></td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CAS</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oromotor dyspraxia</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_9" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired expressive &#x00026; receptive</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_10" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_foxp2-sl-dis.T.foxp2_pathogenic_variants_1_1_1_11" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rss/">Silver-Russell syndrome</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">Gen = generation, mutation across three generations of the family; Mo = mother; MZ = monozygotic; NR = not reported; PDD-NOS = pervasive developmental disorder, not otherwise specified</p></div></dd><dt>1. </dt><dd><div id="foxp2-sl-dis.TF.3.1"><p class="no_margin">Reference sequences for two alternative <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>: <a href="/nuccore/NM_014491.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014491<wbr style="display:inline-block"></wbr>​.3</a>, <a href="/protein/NP_055306.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055306<wbr style="display:inline-block"></wbr>​.1</a> (Isoform I) &#x00026; <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_148898" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM<wbr style="display:inline-block"></wbr>​_148898</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/NP_683696" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP<wbr style="display:inline-block"></wbr>​_683696</a> (Isoform II)</p></div></dd><dt>2. </dt><dd><div id="foxp2-sl-dis.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot et al [2005]</a></p></div></dd><dt>3. </dt><dd><div id="foxp2-sl-dis.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</a></p></div></dd><dt>4. </dt><dd><div id="foxp2-sl-dis.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.turner.2013.2321">Turner et al [2013]</a></p></div></dd><dt>5. </dt><dd><div id="foxp2-sl-dis.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.roll.2010.4848">Roll et al [2010]</a></p></div></dd><dt>6. </dt><dd><div id="foxp2-sl-dis.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2001.519">Lai et al [2001]</a></p></div></dd><dt>7. </dt><dd><div id="foxp2-sl-dis.TF.3.7"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.laffin.2012.928">Laffin et al [2012]</a></p></div></dd><dt>8. </dt><dd><div id="foxp2-sl-dis.TF.3.8"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.feuk.2006.965">Feuk et al [2006]</a></p></div></dd><dt>9. </dt><dd><div id="foxp2-sl-dis.TF.3.9"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.lai.2000.357">Lai et al [2000]</a></p></div></dd><dt>10. </dt><dd><div id="foxp2-sl-dis.TF.3.10"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.shriberg.2006.500">Shriberg et al [2006]</a></p></div></dd><dt>11. </dt><dd><div id="foxp2-sl-dis.TF.3.11"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin et al [2009]</a></p></div></dd><dt>12. </dt><dd><div id="foxp2-sl-dis.TF.3.12"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.adegbola.2015.6848">Adegbola et al [2015]</a></p></div></dd><dt>13. </dt><dd><div id="foxp2-sl-dis.TF.3.13"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.zilina.2012.254">Zilina et al [2012]</a></p></div></dd><dt>14. </dt><dd><div id="foxp2-sl-dis.TF.3.14"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.rice.2012.174">Rice et al [2012]</a></p></div></dd><dt>15. </dt><dd><div id="foxp2-sl-dis.TF.3.15"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.palka.2012.e183">Palka et al [2012]</a></p></div></dd><dt>16. </dt><dd><div id="foxp2-sl-dis.TF.3.16"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.lennon.2007.791">Lennon et al [2007]</a></p></div></dd><dt>17. </dt><dd><div id="foxp2-sl-dis.TF.3.17"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.zeesman.2006.509">Zeesman et al [2006]</a></p></div></dd><dt>18. </dt><dd><div id="foxp2-sl-dis.TF.3.18"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.becker.2015.69">Becker et al [2015]</a></p></div></dd><dt>19. </dt><dd><div id="foxp2-sl-dis.TF.3.19"><p class="no_margin"><a class="bk_pop" href="#foxp2-sl-dis.REF.moralli.2015.36">Moralli et al [2015]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The full-length FOXP2 protein assayed at the cellular level consists of 715 amino acid residues. The protein, Forkhead box protein P2, is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> with zinc finger (residues 346 to 371) and DNA binding (residues 504 to 594) functional domains (<a href="http://www.uniprot.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>). Forkhead box proteins are transcription factors that likely regulate hundreds of downstream target genes, some of which will be critical for development of speech and language.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, including those that disrupt the DNA binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (e.g., p.Arg553His [<a class="bk_pop" href="#foxp2-sl-dis.REF.vernes.2006.3154">Vernes et al 2006</a>]), produce abnormal gene products that cannot bind DNA targets properly, as shown by functional studies of some variants.</p><p>Other pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants may be associated with <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effects, which to date have not been demonstrated in published reports.</p><p>Partial reduction in FOXP2 protein due to large copy number and complex variants (including deletions, translocations, and inversions) affecting one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> also leads to the clinical features of <i>FOXP2-</i>related disorders (<a class="figpopup" href="/books/NBK368474/table/foxp2-sl-dis.T.foxp2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figfoxp2sldisTfoxp2pathogenicvariants" rid-ob="figobfoxp2sldisTfoxp2pathogenicvariants">Table 3</a>).</p></div><div id="foxp2-sl-dis.References"><h2 id="_foxp2-sl-dis_References_">References</h2><div id="foxp2-sl-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.adegbola.2015.6848">Adegbola AA, Cox GF, Bradshaw EM, Hafler DA, Gimelbrant A, Chess A. Monoallelic expression of the human FOXP2 speech gene. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2015;<span class="ref-vol">112</span>:6848–54.</span> [<a href="/pmc/articles/PMC4460484/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4460484</span></a>] [<a href="/pubmed/25422445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25422445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.alcock.2000.17">Alcock KJ, Passingham RE, Watkins KE, Vargha-Khadem F. Oral dyspraxia in inherited speech and language impairment and acquired dysphasia. <span><span class="ref-journal">Brain Lang. </span>2000;<span class="ref-vol">75</span>:17–33.</span> [<a href="/pubmed/11023636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11023636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF3">American Speech-Language-Hearing Association. Childhood apraxia of speech [Position Statement]. Available <a href="http://www.asha.org/policy/PS2007-00277/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2007. Accessed 9-26-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.becker.2015.69">Becker M, Devanna P, Fisher SE, Vernes SC. A chromosomal rearrangement in a child with severe speech and language disorder separates FOXP2 from a functional enhancer. <span><span class="ref-journal">Mol Cytogenet. </span>2015;<span class="ref-vol">8</span>:69.</span> [<a href="/pmc/articles/PMC4546047/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4546047</span></a>] [<a href="/pubmed/26300977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26300977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.clark.2000.2160">Clark M, Carr L, Reilly S, Neville BG. Worster-Drought syndrome, a mild tetraplegic perisylvian cerebral palsy. Review of 47 cases. <span><span class="ref-journal">Brain. </span>2000;<span class="ref-vol">123</span>:2160–70.</span> [<a href="/pubmed/11004132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11004132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.dodd.2003.617">Dodd B, Holm A, Hua Z, Crosbie S. Phonological development: a normative study of British English-speaking children. <span><span class="ref-journal">Clin Linguist Phon. </span>2003;<span class="ref-vol">17</span>:617–43.</span> [<a href="/pubmed/14977026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14977026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.fedorenko.2016.310">Fedorenko E, Morgan A, Murray E, Cardinaux A, Mei C, Tager-Flusberg H, Fisher SE, Kanwisher N. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:310.</span> [<a href="/pmc/articles/PMC4717201/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4717201</span></a>] [<a href="/pubmed/26763793" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26763793</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.fee.1995.189">Fee EJ. The phonological system of a specifically language-impaired population. <span><span class="ref-journal">Clin Linguist Phon. </span>1995;<span class="ref-vol">9</span>:189–209.</span> [<a href="/pubmed/21749311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21749311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.feuk.2006.965">Feuk L, Kalervo A, Lipsanen-Nyman M, Skaug J, Nakabayashi K, Finucane B, Hartung D, Innes M, Kerem B, Nowaczyk MJ, Rivlin J, Roberts W, Senman L, Summers A, Szatmari P, Wong V, Vincent JB, Zeesman S, Osborne LR, Cardy JO, Kere J, Scherer SW, Hannula-Jouppi K. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:965–72.</span> [<a href="/pmc/articles/PMC1698557/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1698557</span></a>] [<a href="/pubmed/17033973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17033973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.fisher.1998.168">Fisher SE, Vargha-Khadem F, Watkins KE, Monaco AP, Pembrey ME. Localisation of a gene implicated in a severe speech and language disorder. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:168–70.</span> [<a href="/pubmed/9462748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9462748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.flipsen.2006.303">Flipsen P. Measuring the intelligibility of conversational speech in children. <span><span class="ref-journal">Clin Linguist Phon. </span>2006;<span class="ref-vol">20</span>:303–12.</span> [<a href="/pubmed/16644588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16644588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.gauthier.2003.172">Gauthier J, Joober R, Mottron L, Laurent S, Fuchs M, De Kimpe V, Rouleau GA. Mutation screening of FOXP2 in individuals diagnosed with autistic disorder. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">118A</span>:172–5.</span> [<a href="/pubmed/12655497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12655497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.han.2014.23">Han TU, Park J, Domingues CF, Moretti-Ferreira D, Paris E, Sainz E, Gutierrez J, Drayna D. A study of the role of the FOXP2 and CNTNAP2 genes in persistent developmental stuttering. <span><span class="ref-journal">Neurobiol Dis. </span>2014;<span class="ref-vol">69</span>:23–31.</span> [<a href="/pmc/articles/PMC4099264/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4099264</span></a>] [<a href="/pubmed/24807205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24807205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.laffin.2012.928">Laffin JJ, Raca G, Jackson CA, Strand EA, Jakielski KJ, Shriberg LD. Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization. <span><span class="ref-journal">Genet Med. </span>2012;<span class="ref-vol">14</span>:928–36.</span> [<a href="/pmc/articles/PMC3563158/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3563158</span></a>] [<a href="/pubmed/22766611" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22766611</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.lai.2000.357">Lai CS, Fisher SE, Hurst JA, Levy ER, Hodgson S, Fox M, Jeremiah S, Povey S, Jamison DC, Green ED, Vargha-Khadem F, Monaco AP. The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:357–68.</span> [<a href="/pmc/articles/PMC1287211/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287211</span></a>] [<a href="/pubmed/10880297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10880297</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.lai.2001.519">Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">413</span>:519–23.</span> [<a href="/pubmed/11586359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11586359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.law.2003.cd004110">Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2003;(3):CD004110.</span> [<a href="/pubmed/12918003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12918003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.lennon.2007.791">Lennon PA, Cooper ML, Peiffer DA, Gunderson KL, Patel A, Peters S, Cheung SW, Bacino CA. Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:791–8.</span> [<a href="/pubmed/17330859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17330859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.li_geois.2016.35192">Li&#x000e9;geois FJ, Hildebrand MS, Bonthrone A, Turner SJ, Scheffer IE, Bahlo M, Connelly A, Morgan AT. Early neuroimaging markers of FOXP2 intragenic deletion. <span><span class="ref-journal">Sci Rep. </span>2016;<span class="ref-vol">6</span>:35192.</span> [<a href="/pmc/articles/PMC5062117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5062117</span></a>] [<a href="/pubmed/27734906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27734906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.macdermot.2005.1074">MacDermot KD, Bonora E, Sykes N, Coupe AM, Lai CS, Vernes SC, Vargha-Khadem F, McKenzie F, Smith RL, Monaco AP, Fisher SE. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:1074–80.</span> [<a href="/pmc/articles/PMC1196445/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196445</span></a>] [<a href="/pubmed/15877281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15877281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.moralli.2015.36">Moralli D, Nudel R, Chan MT, Green CM, Volpi EV, Ben&#x000ed;tez-Burraco A, Newbury DF, Garc&#x000ed;a-Bellido P. Language impairment in a case of a complex chromosomal rearrangement with a breakpoint downstream of FOXP2. <span><span class="ref-journal">Mol Cytogenet. </span>2015;<span class="ref-vol">8</span>:36.</span> [<a href="/pmc/articles/PMC4460787/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4460787</span></a>] [<a href="/pubmed/26060509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26060509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.morgan.2010">Morgan AT, Li&#x000e9;geois F, Vargha-Khadem F. Motor speech outcome as a function of the site of brain pathology: A developmental perspective. Chap 6. In: Maassen B, van Lieshout P, eds. <em>Speech Motor Control: New Developments in Basic and Applied Research.</em> Oxford, UK: Oxford University Press; 2010:95-115.</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.morgan.2008.cd006278">Morgan AT, Vogel AP. Intervention for childhood apraxia of speech. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2008;(3):CD006278.</span> [<a href="/pubmed/18646142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18646142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.murray.2015">Murray E, McCabe P, Ballard KJ. A randomized controlled trial for children with childhood apraxia of speech comparing Rapid Syllable Transition treatment and the Nuffield Dyspraxia Programme -Third edition. J Speech Lang Hear Res. 2015; 58:669-86. [<a href="/pubmed/25807891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25807891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.murray.2014.486">Murray E, McCabe P, Ballard KJ. A systematic review of treatment outcomes for children with childhood apraxia of speech. <span><span class="ref-journal">Am J Speech Lang Pathol. </span>2014;<span class="ref-vol">23</span>:486–504.</span> [<a href="/pubmed/24686844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24686844</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.newbury.2002.1318">Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G, Jannoun L, Slonims V, Stott CM, Merricks MJ, Bolton PF, Bailey AJ, Monaco AP, et al.  FOXP2 is not a major susceptibility gene for autism or specific language impairment. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:1318–27.</span> [<a href="/pmc/articles/PMC447606/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC447606</span></a>] [<a href="/pubmed/11894222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11894222</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.palka.2012.e183">Palka C, Alfonsi M, Mohn A, Cerbo R, Guanciali Franchi P, Fantasia D, Morizio E, Stuppia L, Calabrese G, Zori R, Chiarelli F, Palka G. Mosaic 7q31 deletion involving FOXP2 gene associated with language impairment. <span><span class="ref-journal">Pediatrics. </span>2012;<span class="ref-vol">129</span>:e183–8.</span> [<a href="/pubmed/22144704" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22144704</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.pennington.2009.cd006937">Pennington L, Miller N, Robson S. Speech therapy for children with dysarthria acquired before three years of age. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2009;(4):CD006937.</span> [<a href="/pubmed/19821391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19821391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.potter.2013.31">Potter NL, Nievergelt Y, Shriberg LD. Motor and speech disorders in classic galactosemia. <span><span class="ref-journal">JIMD Rep. </span>2013;<span class="ref-vol">11</span>:31–41.</span> [<a href="/pmc/articles/PMC3755563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3755563</span></a>] [<a href="/pubmed/23546812" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23546812</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.rice.2012.174">Rice GM, Raca G, Jakielski KJ, Laffin JJ, Iyama-Kurtycz CM, Hartley SL, Sprague RE, Heintzelman AT, Shriberg LD. Phenotype of FOXP2 haploinsufficiency in a mother and son. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:174–81.</span> [<a href="/pmc/articles/PMC3319495/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3319495</span></a>] [<a href="/pubmed/22106036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22106036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.reuter.2017.64">Reuter MS, Riess A, Moog U, Briggs TA, Chandler KE, Rauch A, Stampfer M, Steindl K, Glaser D, Joset P, Study DDD, Krumbiegel M, Rabe H, Schulte-Mattler U, Bauer P, Beck-W&#x000f6;dl S, Kohlhase J, Reis A, Zweier C. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum. <span><span class="ref-journal">J Med Genet. </span>2017;<span class="ref-vol">54</span>:64–72.</span> [<a href="/pubmed/27572252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27572252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.roll.2010.4848">Roll P, Vernes SC, Bruneau N, Cillario J, Ponsole-Lenfant M, Massacrier A, Rudolf G, Khalife M, Hirsch E, Fisher SE, Szepetowski P. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:4848–60.</span> [<a href="/pmc/articles/PMC2989892/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2989892</span></a>] [<a href="/pubmed/20858596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20858596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF33">Royal College of Speech and Language Therapists. Policy statement on developmental verbal dyspraxia. Available <a href="http://www.ndp3.org/documents/rcslt2011dvdPolicyStatement.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2011. Accessed 9-26-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.shriberg.1997.273">Shriberg LD, Aram DM, Kwiatkowski J. Developmental apraxia of speech: I. Descriptive and theoretical perspectives. <span><span class="ref-journal">J Speech Lang Hear Res. </span>1997;<span class="ref-vol">40</span>:273–85.</span> [<a href="/pubmed/9130199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9130199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.shriberg.2006.500">Shriberg LD, Ballard KJ, Tomblin JB, Duffy JR, Odell KH, Williams CA. Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2. <span><span class="ref-journal">J Speech Lang Hear Res. </span>2006;<span class="ref-vol">49</span>:500–25.</span> [<a href="/pubmed/16787893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16787893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.shriberg.2011.487">Shriberg LD, Potter NL, Strand EA. Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia. <span><span class="ref-journal">J Speech Lang Hear Res. </span>2011;<span class="ref-vol">54</span>:487–519.</span> [<a href="/pmc/articles/PMC3070858/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3070858</span></a>] [<a href="/pubmed/20966389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20966389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.snowling.2012.27">Snowling MJ, Hulme C. Interventions for children's language and literacy difficulties. <span><span class="ref-journal">Int J Lang Commun Disord. </span>2012;<span class="ref-vol">47</span>:27–34.</span> [<a href="/pmc/articles/PMC3429860/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3429860</span></a>] [<a href="/pubmed/22268899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22268899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.tomblin.2009.1157">Tomblin JB, O'Brien M, Shriberg LD, Williams C, Murray J, Patil S, Bjork J, Anderson S, Ballard K. Language features in a mother and daughter of a chromosome 7;13 translocation involving FOXP2. <span><span class="ref-journal">J Speech Lang Hear Res. </span>2009;<span class="ref-vol">52</span>:1157–74.</span> [<a href="/pmc/articles/PMC2760059/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2760059</span></a>] [<a href="/pubmed/19797137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19797137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.turner.2013.2321">Turner SJ, Hildebrand MS, Block S, Damiano J, Fahey M, Reilly S, Bahlo M, Scheffer IE, Morgan AT. Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2321–6.</span> [<a href="/pubmed/23918746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23918746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.varghakhadem.2005.131">Vargha-Khadem F, Gadian DG, Copp A, Mishkin M. FOXP2 and the neuroanatomy of speech and language. <span><span class="ref-journal">Nat Rev Neurosci. </span>2005;<span class="ref-vol">6</span>:131–8.</span> [<a href="/pubmed/15685218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15685218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.varghakhadem.1995.930">Vargha-Khadem F, Watkins K, Alcock K, Fletcher P, Passingham R. Praxic and nonverbal cognitive deficits in a large family with a genetically transmitted speech and language disorder. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1995;<span class="ref-vol">92</span>:930–3.</span> [<a href="/pmc/articles/PMC42734/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC42734</span></a>] [<a href="/pubmed/7846081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7846081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.varghakhadem.1998.12695">Vargha-Khadem F, Watkins KE, Price CJ, Ashburner J, Alcock KJ, Connelly A, Frackowiak RS, Friston KJ, Pembrey ME, Mishkin M, Gadian DG, Passingham RE. Neural basis of an inherited speech and language disorder. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:12695–700.</span> [<a href="/pmc/articles/PMC22893/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC22893</span></a>] [<a href="/pubmed/9770548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9770548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.velleman.2011.108">Velleman SL, Mervis CB. Children with 7q11.23 Duplication Syndrome: Speech, Language, Cognitive, and Behavioral Characteristics and their Implications for Intervention. <span><span class="ref-journal">Perspect Lang Learn Educ. </span>2011;<span class="ref-vol">18</span>:108–16.</span> [<a href="/pmc/articles/PMC3383616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3383616</span></a>] [<a href="/pubmed/22754604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22754604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.vernes.2006.3154">Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, Bird LE, Davies KE, Fisher SE. Functional genetic analysis of mutations implicated in a human speech and language disorder. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>:3154–67.</span> [<a href="/pubmed/16984964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16984964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.watkins.2002.452">Watkins KE, Dronkers NF, Vargha-Khadem F. Behavioural analysis of an inherited speech and language disorder: comparison with acquired aphasia. <span><span class="ref-journal">Brain. </span>2002;<span class="ref-vol">125</span>:452–64.</span> [<a href="/pubmed/11872604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11872604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.white.2010.821">White SM, Morgan A, Da Costa A, Lacombe D, Knight SJ, Houlston R, Whiteford ML, Newbury-Ecob RA, Hurst JA. The phenotype of Floating-Harbor syndrome in 10 patients. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:821–9.</span> [<a href="/pubmed/20358590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20358590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.zeesman.2006.509">Zeesman S, Nowaczyk MJ, Teshima I, Roberts W, Cardy JO, Brian J, Senman L, Feuk L, Osborne LR, Scherer SW. Speech and language impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:509–14.</span> [<a href="/pubmed/16470794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="foxp2-sl-dis.REF.zilina.2012.254">Zilina O, Reimand T, Zjablovskaja P, M&#x000e4;nnik K, M&#x000e4;nnamaa M, Traat A, Puusepp-Benazzouz H, Kurg A, Ounap K. Maternally and paternally inherited deletion of 7q31 involving the FOXP2 gene in two families. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:254–6.</span> [<a href="/pubmed/22105961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22105961</span></a>]</div></li></ul></div></div><div id="foxp2-sl-dis.Chapter_Notes"><h2 id="_foxp2-sl-dis_Chapter_Notes_">Chapter Notes</h2><div id="foxp2-sl-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>2 February 2017 (am) Revision: based on <a class="bk_pop" href="#foxp2-sl-dis.REF.reuter.2017.64">Reuter et al [2017]</a></div></li><li class="half_rhythm"><div>23 June 2016 (bp) Review posted live</div></li><li class="half_rhythm"><div>4 August 2015 (am, msh) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK368474</span><span class="label">PMID: <a href="/pubmed/27336128" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">27336128</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fragilex/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mota/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK368474&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK368474/?report=reader">PubReader</a></li><li><a href="/books/NBK368474/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK368474" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK368474" style="display:none" title="Cite this Page"><div class="bk_tt">Morgan A, Fisher SE, Scheffer I, et al. FOXP2-Related Speech and Language Disorders. 2016 Jun 23 [Updated 2017 Feb 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK368474/pdf/Bookshelf_NBK368474.pdf">PDF version of this page</a> (572K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#foxp2-sl-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#foxp2-sl-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#foxp2-sl-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#foxp2-sl-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#foxp2-sl-dis.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#foxp2-sl-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#foxp2-sl-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#foxp2-sl-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#foxp2-sl-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#foxp2-sl-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#foxp2-sl-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#foxp2-sl-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=93986[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FOXP2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4284282" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4284282" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4284282" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4284282" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23918746" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria.</a><span class="source">[Am J Med Genet A. 2013]</span><div class="brieflinkpop offscreen_noflow">Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Turner SJ, Hildebrand MS, Block S, Damiano J, Fahey M, Reilly S, Bahlo M, Scheffer IE, Morgan AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2013 Sep; 161A(9):2321-6. Epub 2013 Aug 5.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29845607" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Interventions for childhood apraxia of speech.</a><span class="source">[Cochrane Database Syst Rev. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Interventions for childhood apraxia of speech.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Morgan AT, Murray E, Liégeois FJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cochrane Database Syst Rev. 2018 May 30; 5:CD006278. Epub 2018 May 30.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301696" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald-McGinn DM, Emanuel BS, Zackai EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27683935" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Myers KA, Scheffer IE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27336128" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27336128" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412ccdd21425a25ba927b">FOXP2-Related Speech and Language Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">FOXP2-Related Speech and Language Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:54:20-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B96F7E04026F100000000068A0249&amp;ncbi_session=CE8B96F7E0412CC1_1674SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK368474%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK368474&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK368474/&amp;ncbi_pagename=FOXP2-Related Speech and Language Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B96F7E0412CC1_1674SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>